Abstract
Objective
South Korea has an increasing prevalence of diabetes and a relatively high burden of tuberculosis. We aimed to determine the prevalence of diabetes in patients with active pulmonary tuberculosis (PTB) and examine the effect of diabetes on tuberculosis treatment outcomes.
Setting and Design
Data from patients ≥30 years diagnosed with and treated for PTB between January 2010 and December 2012 at Severance Hospital, a 2000-bed tertiary referral hospital in Seoul, South Korea, were analyzed and compared with data from a contemporaneous general population sample extracted from KNHANES V.
Results
Diabetes prevalence was 24.2% (252/1044) among patients with PTB and 11.6% (1700/14,655) among controls. Diabetes [odds ratios (OR) 2.56, 95% confidence interval (CI) 1.56–4.21, P < 0.001], male sex (OR 1.93, 95% CI 1.08–3.44, P = 0.027), and cavitary disease (OR 2.08, 95% CI 1.29–3.35, P = 0.003) were significant risk factors for 2-month culture positivity. Diabetes was the only factor associated with unsuccessful treatment outcomes (OR 1.67, 95% CI 1.03–2.70, P = 0.039).
Conclusion
The prevalence of diabetes was markedly higher in patients with PTB than in a sample of the general South Korean population. Diabetes may delay sputum conversion and adversely affect treatment outcomes; detection and management of diabetes in patients with PTB is crucial.
Similar content being viewed by others
References
World Health Organisation (2015) Global tuberculosis report 2015. World Health Organization, Geneva
Kim DJ (2011) The epidemiology of diabetes in Korea. Diabetes Metab J 35(4):303–308
Baker MA, Harries AD, Jeon CY et al (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 9:81
Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):1091–1101
Dooley KE, Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 9(12):737–746
American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35 Suppl 1:S64–S71
Blumberg HM, Burman WJ, Chaisson RE et al (2003) American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167(4):603–662
Jo KW, Yoo JW, Hong Y et al (2014) Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen. Respir Med 108(4):654–659
Alisjahbana B, van Crevel R, Sahiratmadja E et al (2006) Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 10(6):696–700
Sulaiman SA, Khan AH, Muttalif AR et al (2013) Impact of diabetes mellitus on treatment outcomes of tuberculosis patients in tertiary care setup. Am J Med Sci 345(4):321–325
Kornfeld H, West K, Kane K et al (2016) High prevalence and heterogeneity of diabetes in patients with TB in South India: a report from the effects of diabetes on tuberculosis severity (E.S) Study. Chest 149(6):1501–1508
Kim SJ, Hong YP, Lew WJ et al (1995) Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 76(6):529–533
Bloomgarden ZT (2003) Inflammation and insulin resistance. Diabetes Care 26(5):1619–1623
Chang FY, Shaio MF (1995) Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 28(2):137–146
Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187–201
Wang CH, Yu CT, Lin HC et al (1999) Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 79(4):235–242
Alisjahbana B, Sahiratmadja E, Nelwan EJ et al (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45(4):428–435
Rekha VVB, Balasubramanian R, Swaminathan S et al (2007) Sputum conversion at the end of intensive phase of category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors. Indian J Med Res 126(5):452–458
Singla R, Khan N, Al-Sharif N et al (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 10(1):74–79
Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L et al (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68(3):214–220
Shariff NM, Safian N (2015) Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: a case control study. Int J Mycobacteriol 4(4):323–329
Viswanathan V, Vigneswari A, Selvan K et al (2014) Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis—a report from South India. J Diabetes Complicat 28(2):162–165
Jiménez-Corona ME, Cruz-Hervert LP, García-García L et al (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68(3):214–220
Dooley KE, Tang T, Golub JE et al (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639
Güler M, Ünsal E, Dursun B et al (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61(2):231–235
Restrepo BI, Fisher-Hoch SP, Smith B et al (2008) Short report: Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 79(4):541–544
Leung CC, Lam TH, Chan WM et al (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167(12):1486–1494
Restrepo BI, Fisher-Hoch SP, Pino PA et al (2008) Tuberculosis in poorly controlled type 2 diabetes: Altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47(5):634–641
Yamashiro S, Kawakami K, Uezu K et al (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139(1):57–64
Acknowledgements
This study was supported by a faculty research grant of Yonsei University College of Medicine for 2013 (6-2013-0056).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
The research protocol was approved by the Institutional Review Board (IRB) of Severance Hospital (IRB No. 4-2012-0840).
Informed Consent
Informed consent was waived due to the retrospective nature of the study.
Rights and permissions
About this article
Cite this article
Lee, E.H., Lee, J.M., Kang, Y.A. et al. Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea. Lung 195, 209–215 (2017). https://doi.org/10.1007/s00408-017-9978-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-017-9978-4